529 related articles for article (PubMed ID: 26607642)
1. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Zhu W; Jia L; Chen G; Zhao H; Sun X; Meng X; Zhao X; Xing L; Yu J; Zheng M
Oncotarget; 2016 Jul; 7(30):48607-48613. PubMed ID: 27224910
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Zhao H; Zhu W; Zhao X; Li X; Zhou Z; Zheng M; Meng X; Kong L; Zhang S; He D; Xing L; Yu J
JAMA Dermatol; 2022 Jul; 158(7):779-786. PubMed ID: 35648426
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
Xie J; Jia L; Xie P; Yin X; Zhu W; Zhao H; Wang X; Meng X; Xing L; Zhao H; Li X
Sci Rep; 2023 Aug; 13(1):13865. PubMed ID: 37620508
[TBL] [Abstract][Full Text] [Related]
5. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
6. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients.
Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM
Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Zhu W; Mei H; Jia L; Zhao H; Li X; Meng X; Zhao X; Xing L; Yu J
Invest New Drugs; 2020 Aug; 38(4):1129-1136. PubMed ID: 31701429
[TBL] [Abstract][Full Text] [Related]
8. Possible use of epigallocatechin-3-gallate (EGCG) as prevention of radio dermatitis in radiotherapy treated breast cancer patients.
Bonucci M; Fioranelli M; Roccia MG; Lotti T
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28394429
[No Abstract] [Full Text] [Related]
9. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
10. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
12. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of acute skin toxicity of breast radiotherapy using thermography: Results of a prospective single-centre trial.
Maillot O; Leduc N; Atallah V; Escarmant P; Petit A; Belhomme S; Sargos P; Vinh-Hung V
Cancer Radiother; 2018 May; 22(3):205-210. PubMed ID: 29678596
[TBL] [Abstract][Full Text] [Related]
14. Photobiomodulation therapy for the management of radiation-induced dermatitis : A single-institution experience of adjuvant radiotherapy in breast cancer patients after breast conserving surgery.
Strouthos I; Chatzikonstantinou G; Tselis N; Bon D; Karagiannis E; Zoga E; Ferentinos K; Maximenko J; Nikolettou-Fischer V; Zamboglou N
Strahlenther Onkol; 2017 Jun; 193(6):491-498. PubMed ID: 28243723
[TBL] [Abstract][Full Text] [Related]
15. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
16. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.
Karbasforooshan H; Hosseini S; Elyasi S; Fani Pakdel A; Karimi G
Phytother Res; 2019 Feb; 33(2):379-386. PubMed ID: 30479044
[TBL] [Abstract][Full Text] [Related]
17. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors Increasing the Risk of Radiation Toxicity in Patients with Early Breast Cancer.
Abdeltawab AA; Ali SA; Mostafa HG; Hassan MA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):145-149. PubMed ID: 33507692
[TBL] [Abstract][Full Text] [Related]
19. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
20. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
Pommier P; Gomez F; Sunyach MP; D'Hombres A; Carrie C; Montbarbon X
J Clin Oncol; 2004 Apr; 22(8):1447-53. PubMed ID: 15084618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]